Said Ibrahimi, MD
Neurology · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 29
- 6 carriers
- Office
- 1
Offices
1 location
Plans that list them
29 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ibrahimi’s office at (669) 235-4188 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
29 of 29 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
California Medical Board record
Licence A133381 · Current
Licensed to practise in California · since 2014 · expires 2028-02-29 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$263,019
Medicare paid this office $263,019 for 309 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Measurement of brain wave activity (eeg), awake and drowsy | 106 | $49,262 | $452 |
| Measurement of brain wave activity (eeg), digital analysis | 105 | $35,741 | $331 |
| Long return visit (40+ min) | 136 | $31,541 | $175 |
| Ultrasound of within the brain blood flow following medication | 75 | $24,516 | $327 |
| Return visit (30+ min) | 146 | $23,102 | $118 |
See all 18 services
| Measurement of brain wave activity (eeg), awake and drowsy | 106 | $49,262 | $452 |
| Measurement of brain wave activity (eeg), digital analysis | 105 | $35,741 | $331 |
| Long return visit (40+ min) | 136 | $31,541 | $175 |
| Ultrasound of within the brain blood flow following medication | 75 | $24,516 | $327 |
| Return visit (30+ min) | 146 | $23,102 | $118 |
| Complete ultrasound of within the brain blood flow | 75 | $23,090 | $304 |
| New patient visit (60+ min) | 108 | $21,912 | $203 |
| Ultrasound of both sides of head and neck blood flow | 70 | $14,364 | $202 |
| Ultrasound of within the brain blood flow for blood clots | 75 | $13,868 | $185 |
| Evaluation of neuropsychological test, first hour | 39 | $4,565 | $111 |
| New patient visit (45+ min) | 25 | $3,835 | $153 |
| Nerve test | 12 | $2,729 | $227 |
| Test for abnormal eye movement using a rotating chair | 15 | $2,330 | $155 |
| Evaluation and testing for balance with recording | 17 | $1,809 | $106 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 39 | $1,558 | $38 |
| Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, first 20 minutes per calendar month | 12 | $815 | $54 |
| Test to assess balance during warm and cool irrigation in both ears | 18 | $732 | $41 |
| Use of electrodes during balance testing | 18 | $230 | $13 |
Who their Medicare patients are
309 Original Medicare patients in 2024. Average age 72 · Under 65 14% · 85 and older 12% · Women 57% · Also on Medicaid 82% · Health risk score 1.51. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 75% · Diabetes 46% · Stroke 40% · Coronary heart disease 33% · Depression 31% · Dementia 24% · Chronic kidney disease 22% · Heart failure 19% · Atrial fibrillation 18% · COPD 10% · Cancer 8%.
The office billed $2,530,674, Medicare allowed $338,711 and paid $263,019; for 1,264 services of 31 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 309 | 1,264 | 72 | 1.51 | $2,530,674 | $263,019 |
| 2023 | 312 | 1,492 | 72 | 1.51 | $2,885,410 | $265,573 |
| 2022 | 279 | 1,371 | 71 | 1.51 | $2,349,752 | $235,967 |
| 2021 | 213 | 945 | 71 | 1.51 | $1,060,312 | $155,992 |
| 2020 | 180 | 674 | 69 | 1.64 | $771,377 | $107,281 |
| 2019 | 191 | 890 | 71 | 1.81 | $801,454 | $140,874 |
| 2018 | 240 | 831 | 72 | 2.04 | $476,990 | $128,267 |
| 2017 | 233 | 617 | 74 | 2.42 | $251,397 | $87,190 |
| 2016 | 187 | 552 | 75 | 1.91 | $144,350 | $76,630 |
| 2015 | 273 | 837 | 74 | 2.36 | $192,131 | $96,000 |
| 2014 | 319 | 2,637 | 73 | 1.23 | $488,768 | $177,657 |
| 2013 | 271 | 1,324 | 73 | 1.33 | $407,444 | $149,310 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 22 services
| Measurement of brain wave activity (eeg), awake and drowsy | 110 | $46,343 | $414 |
| Ultrasound of within the brain blood flow following medication | 105 | $33,034 | $303 |
| Complete ultrasound of within the brain blood flow | 107 | $31,907 | $287 |
| Return visit (30+ min) | 178 | $31,673 | $112 |
| Long return visit (40+ min) | 119 | $25,663 | $162 |
| Ultrasound of within the brain blood flow for blood clots | 105 | $18,828 | $173 |
| New patient visit (60+ min) | 98 | $18,535 | $189 |
| Ultrasound of both sides of head and neck blood flow | 48 | $9,925 | $207 |
| New patient visit (45+ min) | 63 | $8,067 | $128 |
| Muscle electrical test | 33 | $7,382 | $101 |
| Nerve test | 25 | $6,068 | $243 |
| Evaluation of neuropsychological test, first hour | 41 | $5,478 | $119 |
| Measurement of brain wave activity (eeg), digital analysis | 13 | $3,775 | $290 |
| Nerve test | 17 | $3,547 | $209 |
| Test for abnormal eye movement using a rotating chair | 23 | $3,186 | $139 |
| Evaluation and testing for balance with recording | 26 | $2,805 | $108 |
| Short return visit (20+ min) | 23 | $2,271 | $81 |
| Muscle electrical test | 20 | $1,739 | $87 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 41 | $1,734 | $38 |
| Test to assess balance during warm and cool irrigation in both ears | 26 | $1,029 | $40 |
| Administration of psychological or neuropsychological test by technician, each additional 30 minutes | 15 | $581 | $39 |
| Use of electrodes during balance testing | 26 | $311 | $12 |
2022: 20 services
| Measurement of brain wave activity (eeg), awake and drowsy | 106 | $45,358 | $412 |
| Return visit (30+ min) | 174 | $35,890 | $113 |
| Ultrasound of within the brain blood flow following medication | 87 | $26,069 | $300 |
| Complete ultrasound of within the brain blood flow | 89 | $25,374 | $285 |
| Long return visit (40+ min) | 80 | $19,018 | $170 |
| Ultrasound of within the brain blood flow for blood clots | 87 | $15,225 | $175 |
| Muscle electrical test | 53 | $12,968 | $105 |
| New patient visit (60+ min) | 64 | $12,545 | $196 |
| New patient visit (45+ min) | 93 | $11,814 | $127 |
| Nerve test | 36 | $7,815 | $211 |
| Nerve test | 30 | $7,551 | $252 |
| Evaluation of neuropsychological test, first hour | 37 | $4,507 | $116 |
| Short return visit (20+ min) | 32 | $3,255 | $74 |
| Muscle electrical test | 25 | $2,251 | $90 |
| Test for abnormal eye movement using a rotating chair | 11 | $1,485 | $135 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 37 | $1,410 | $36 |
| Evaluation and testing for balance with recording | 12 | $1,290 | $107 |
| Administration of psychological or neuropsychological test by technician, each additional 30 minutes | 17 | $637 | $35 |
| Test to assess balance during warm and cool irrigation in both ears | 12 | $484 | $40 |
| Use of electrodes during balance testing | 12 | $139 | $12 |
2021: 17 services
| Return visit (30+ min) | 144 | $27,650 | $112 |
| Long return visit (40+ min) | 81 | $22,086 | $171 |
| Measurement of brain wave activity (eeg), awake and drowsy | 37 | $16,494 | $412 |
| New patient visit (60+ min) | 75 | $15,065 | $201 |
| Complete ultrasound of within the brain blood flow | 45 | $13,995 | $292 |
| Ultrasound of within the brain blood flow following medication | 43 | $13,810 | $300 |
| Muscle electrical test | 37 | $9,372 | $107 |
| Nerve test | 27 | $7,442 | $266 |
| Ultrasound of within the brain blood flow for blood clots | 39 | $7,179 | $175 |
| New patient visit (45+ min) | 38 | $5,874 | $155 |
| Nerve test | 13 | $2,984 | $230 |
| Muscle electrical test | 24 | $2,410 | $93 |
| Short return visit (20+ min) | 17 | $2,053 | $86 |
| Test for abnormal eye movement using a rotating chair | 12 | $1,543 | $129 |
| Evaluation and testing for balance with recording | 13 | $1,420 | $109 |
| Test to assess balance during warm and cool irrigation in both ears | 12 | $495 | $41 |
| Use of electrodes during balance testing | 12 | $131 | $11 |
2020: 12 services
| Long return visit (40+ min) | 72 | $14,571 | $122 |
| Return visit (30+ min) | 91 | $11,699 | $81 |
| Measurement of brain wave activity (eeg), awake and drowsy | 28 | $11,666 | $389 |
| Ultrasound of within the brain blood flow following medication | 39 | $11,605 | $276 |
| New patient visit (60+ min) | 65 | $11,591 | $178 |
| Complete ultrasound of within the brain blood flow | 38 | $10,622 | $266 |
| Muscle electrical test | 31 | $6,497 | $100 |
| Ultrasound of within the brain blood flow for blood clots | 30 | $5,836 | $177 |
| Nerve test | 17 | $4,734 | $263 |
| New patient visit (45+ min) | 30 | $4,298 | $143 |
| Muscle electrical test | 21 | $1,843 | $88 |
| Short return visit (20+ min) | 11 | $883 | $68 |
2019: 14 services
| Return visit (30+ min) | 120 | $23,016 | $95 |
| Measurement of brain wave activity (eeg), awake and asleep | 33 | $15,536 | $444 |
| Complete ultrasound of within the brain blood flow | 48 | $12,999 | $245 |
| Ultrasound of within the brain blood flow following medication | 41 | $11,406 | $248 |
| New patient visit (60+ min) | 61 | $11,179 | $183 |
| Long return visit (40+ min) | 54 | $11,155 | $130 |
| Muscle electrical test | 48 | $9,597 | $94 |
| Nerve test | 32 | $8,933 | $255 |
| New patient visit (45+ min) | 69 | $8,638 | $125 |
| Ultrasound of within the brain blood flow for blood clots | 40 | $7,742 | $172 |
| Measurement of brain wave activity (eeg), awake and drowsy | 18 | $6,817 | $379 |
| Ultrasound of both sides of head and neck blood flow | 16 | $3,355 | $210 |
| Nerve test | 14 | $3,162 | $226 |
| Short return visit (20+ min) | 20 | $1,539 | $70 |
2018: 18 services
| Critical care, first 30-74 minutes | 49 | $24,263 | $193 |
| Measurement of brain wave activity (eeg), awake and asleep | 30 | $12,951 | $432 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 72 | $12,628 | $171 |
| Return visit (30+ min) | 67 | $11,132 | $97 |
| Ultrasound of within the brain blood flow following medication | 33 | $8,065 | $244 |
| New patient visit (45+ min) | 53 | $7,433 | $140 |
| Ultrasound of within the brain blood flow for blood clots | 35 | $5,940 | $170 |
| Long return visit (40+ min) | 31 | $5,921 | $129 |
| Complete ultrasound of within the brain blood flow | 35 | $5,575 | $159 |
| Muscle electrical test | 26 | $5,177 | $91 |
| Ultrasound of both sides of head and neck blood flow | 27 | $4,729 | $175 |
| New patient visit (60+ min) | 22 | $3,759 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $3,464 | $94 |
| Nerve test | 13 | $3,324 | $256 |
| Nerve test | 12 | $2,800 | $233 |
| Measurement of brain wave activity (eeg), awake and drowsy | 11 | $2,232 | $203 |
| Critical care, each additional 30 minutes | 21 | $2,158 | $98 |
| Measurement of brain wave activity (eeg), awake and asleep | 36 | $2,020 | $53 |
2017: 10 services
| Critical care, first 30-74 minutes | 60 | $30,395 | $188 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 112 | $19,850 | $174 |
| Measurement of brain wave activity (eeg), awake and asleep | 16 | $6,325 | $372 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $4,938 | $90 |
| Measurement of brain wave activity (eeg), awake and asleep | 60 | $4,383 | $51 |
| Return visit (30+ min) | 24 | $3,658 | $96 |
| Critical care, each additional 30 minutes | 34 | $3,401 | $94 |
| New patient visit (45+ min) | 23 | $3,321 | $144 |
| New patient visit (60+ min) | 12 | $2,150 | $179 |
| Muscle electrical test | 12 | $1,977 | $86 |
2016: 8 services
| Critical care, first 30-74 minutes | 57 | $33,005 | $194 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 84 | $15,178 | $176 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $7,357 | $92 |
| Critical care, each additional 30 minutes | 46 | $5,006 | $98 |
| Muscle electrical test | 24 | $4,106 | $86 |
| Measurement of brain wave activity (eeg), awake and asleep | 52 | $3,069 | $52 |
| Nerve test | 12 | $2,875 | $240 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,350 | $64 |
2015: 9 services
| Critical care, first 30-74 minutes | 49 | $35,240 | $193 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 133 | $24,896 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 83 | $12,284 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 56 | $5,373 | $65 |
| Measurement of brain wave activity (eeg), awake and asleep | 75 | $4,515 | $53 |
| Critical care, each additional 30 minutes | 23 | $2,950 | $98 |
| Return visit (30+ min) | 42 | $2,453 | $55 |
| Long return visit (40+ min) | 18 | $1,784 | $78 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,707 | $122 |
2014: 30 services
| Return visit (30+ min) | 164 | $24,608 | $81 |
| Long return visit (40+ min) | 115 | $20,932 | $105 |
| Nerve test | 73 | $17,270 | $233 |
| New patient visit (60+ min) | 91 | $13,949 | $153 |
| Muscle electrical test | 76 | $11,522 | $69 |
| Nerve test | 56 | $11,199 | $200 |
| New patient visit (45+ min) | 85 | $10,582 | $124 |
| Measurement of brain wave activity (eeg), awake and asleep | 22 | $6,911 | $314 |
| Testing of autonomic (sympathetic) nervous system function | 40 | $6,330 | $158 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $5,549 | $159 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 11 | $4,426 | $369 |
| Measurement of brain wave activity (eeg), awake and drowsy | 16 | $4,398 | $275 |
| Measurement of brain wave activity (eeg), 41-60 minutes | 11 | $4,039 | $337 |
| Molecular pathology procedure; physician interpretation and report | 39 | $3,482 | $15 |
| Short return visit (20+ min) | 46 | $3,066 | $55 |
| Test for abnormal eye movement using a rotating chair | 33 | $2,961 | $80 |
| Evaluation and testing for balance with recording | 34 | $2,695 | $69 |
| Testing of autonomic nervous system function and heart rate response to deep breathing | 35 | $2,397 | $68 |
| Exam of neurobehavioral status, first hour | 22 | $1,720 | $72 |
| Placement of scalp electrodes for assessment and recording of responses from several areas of the nerve-brain hearing system | 17 | $1,531 | $90 |
| Assessment and recording of balance system during irrigation of both ears | 32 | $1,515 | $12 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,299 | $81 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 59 | $1,137 | $14 |
| Neuropsychological testing by a computer with interpretation and report by a qualified healthcare professional | 29 | $1,119 | $36 |
| Muscle electrical test | 16 | $1,095 | $46 |
| Use of electrodes during balance testing | 32 | $956 | $4 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 12 | $872 | $73 |
| Psychological testing with interpretation and report by computer | 22 | $501 | $21 |
| Test or measurement for functional capacity, each 15 minutes | 19 | $496 | $26 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 25 | $250 | $10 |
2013: 23 services
| Long return visit (40+ min) | 111 | $24,867 | $105 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 59 | $23,611 | $394 |
| Nerve test | 64 | $15,758 | $228 |
| New patient visit (60+ min) | 85 | $12,839 | $151 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 79 | $12,421 | $153 |
| Testing of autonomic (sympathetic) nervous system function | 38 | $7,968 | $199 |
| Nerve test | 37 | $7,363 | $194 |
| Muscle electrical test | 51 | $6,870 | $63 |
| Critical care, first 30-74 minutes | 17 | $6,425 | $169 |
| Return visit (30+ min) | 41 | $4,193 | $78 |
| Short return visit (20+ min) | 57 | $3,906 | $54 |
| Muscle electrical test | 38 | $3,021 | $46 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,417 | $78 |
| New patient visit (45+ min) | 14 | $1,756 | $125 |
| Exam of neurobehavioral status, first hour | 20 | $1,713 | $69 |
| Placement of scalp electrodes for assessment and recording of responses from several areas of the nerve-brain hearing system | 17 | $1,687 | $99 |
| Neuropsychological testing by a computer with interpretation and report by a qualified healthcare professional | 18 | $1,403 | $78 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 57 | $1,167 | $16 |
| New patient visit (30+ min) | 14 | $1,157 | $83 |
| Critical care, each additional 30 minutes | 11 | $1,100 | $85 |
| Psychological testing with interpretation and report by computer | 19 | $1,012 | $53 |
| Measurement of brain wave activity (eeg), 41-60 minutes | 12 | $520 | $43 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 42 | $445 | $10 |
Medicaid work
$590,248 in 2024
Medicaid paid $590,248 for 3,474 billed services this clinician did in 2024, up to 82 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electroencephalogram (EEG); including recording awake and drowsy | 381 | $131,412 |
| Digital analysis of electroencephalogram (EEG) (eg, for epileptic spike analysis) | 375 | $95,128 |
| Long return visit (40+ min) | 540 | $73,445 |
| New patient visit (60+ min) | 304 | $60,629 |
| Return visit (30+ min) | 692 | $55,973 |
| DUPLEX SCAN EXTRACRANIAL ART COMPL BI STUDY | 246 | $39,631 |
| TRANSCRANIAL DOPPLER STDY INTRACRANIAL ART COMPL | 194 | $32,296 |
| New patient visit (45+ min) | 170 | $28,076 |
| Transcranial Doppler study of the intracranial arteries; vasoreactivity study | 153 | $27,609 |
| Transcranial Doppler study of the intracranial arteries; emboli detection without intravenous microbubble injection | 145 | $22,040 |
| Muscle electrical test | 42 | $6,541 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 48 | $4,189 |
| 2024 | 3,474 | 20 | 82 | $590,248 |
| 2023 | 4,177 | 23 | 91 | $495,102 |
| 2022 | 3,250 | 17 | 98 | $318,068 |
| 2021 | 2,011 | 15 | 95 | $182,596 |
| 2020 | 1,141 | 9 | 45 | $102,055 |
| 2019 | 686 | 6 | 46 | $69,055 |
| 2018 | 288 | 7 | 35 | $31,804 |
See the largest Medicaid services in earlier years
2023
| Electroencephalogram (EEG); including recording awake and drowsy | 445 | $108,911 |
| Return visit (30+ min) | 946 | $67,791 |
| Long return visit (40+ min) | 547 | $54,558 |
| TRANSCRANIAL DOPPLER STDY INTRACRANIAL ART COMPL | 315 | $40,771 |
| New patient visit (60+ min) | 210 | $38,964 |
| Transcranial Doppler study of the intracranial arteries; vasoreactivity study | 259 | $33,902 |
| Transcranial Doppler study of the intracranial arteries; emboli detection without intravenous microbubble injection | 260 | $29,434 |
| Muscle electrical test | 107 | $15,328 |
| New patient visit (45+ min) | 113 | $13,677 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 172 | $13,455 |
| DUPLEX SCAN EXTRACRANIAL ART COMPL BI STUDY | 128 | $12,739 |
| Nerve test | 72 | $12,642 |
2022
| Return visit (30+ min) | 943 | $61,701 |
| Electroencephalogram (EEG); including recording awake and drowsy | 329 | $57,874 |
| TRANSCRANIAL DOPPLER STDY INTRACRANIAL ART COMPL | 242 | $32,251 |
| Long return visit (40+ min) | 316 | $29,100 |
| Transcranial Doppler study of the intracranial arteries; vasoreactivity study | 210 | $26,797 |
| Transcranial Doppler study of the intracranial arteries; emboli detection without intravenous microbubble injection | 201 | $25,997 |
| Muscle electrical test | 216 | $20,901 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 178 | $12,127 |
| New patient visit (60+ min) | 65 | $11,210 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 130 | $9,558 |
| Nerve test | 76 | $9,175 |
| New patient visit (45+ min) | 98 | $8,978 |
2021
| Return visit (30+ min) | 719 | $46,756 |
| Long return visit (40+ min) | 412 | $38,380 |
| Muscle electrical test | 177 | $20,561 |
| Electroencephalogram (EEG); including recording awake and drowsy | 84 | $13,447 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 107 | $11,757 |
| TRANSCRANIAL DOPPLER STDY INTRACRANIAL ART COMPL | 72 | $11,190 |
| Transcranial Doppler study of the intracranial arteries; vasoreactivity study | 67 | $9,128 |
| Transcranial Doppler study of the intracranial arteries; emboli detection without intravenous microbubble injection | 60 | $6,254 |
| Nerve test | 56 | $5,207 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 45 | $4,949 |
| Nerve test | 31 | $4,064 |
| New patient visit (45+ min) | 84 | $3,910 |
2020
| Long return visit (40+ min) | 368 | $33,044 |
| Return visit (30+ min) | 431 | $25,216 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 96 | $10,851 |
| Muscle electrical test | 77 | $9,275 |
| TRANSCRANIAL DOPPLER STDY INTRACRANIAL ART COMPL | 49 | $8,921 |
| Transcranial Doppler study of the intracranial arteries; vasoreactivity study | 50 | $7,046 |
| Nerve test | 30 | $4,053 |
| New patient visit (60+ min) | 25 | $2,107 |
| Transcranial Doppler study of the intracranial arteries; emboli detection without intravenous microbubble injection | 15 | $1,541 |
2019
| Return visit (30+ min) | 482 | $40,103 |
| New patient visit (45+ min) | 63 | $10,246 |
| Long return visit (40+ min) | 82 | $8,298 |
| Muscle electrical test | 28 | $5,090 |
| TRANSCRANIAL DOPPLER STDY INTRACRANIAL ART COMPL | 14 | $2,726 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 17 | $2,592 |
2018
| Return visit (30+ min) | 201 | $19,724 |
| New patient visit (45+ min) | 24 | $3,855 |
| Long return visit (40+ min) | 13 | $2,361 |
| Transcranial Doppler study of the intracranial arteries; emboli detection without intravenous microbubble injection | 12 | $1,588 |
| Electroencephalogram (EEG); including recording awake and asleep | 14 | $1,532 |
| Transcranial Doppler study of the intracranial arteries; vasoreactivity study | 12 | $1,387 |
| TRANSCRANIAL DOPPLER STDY INTRACRANIAL ART COMPL | 12 | $1,357 |
Drugs they prescribed that Part D paid
$373,136
Pharmacies billed $373,136 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,953 generic and fewer than 11 brand-name prescriptions · $373,136 in drug cost · 79 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Nurtec Odt | 53 | $73,468 | $1,386 |
| Nourianz | 19 | $46,892 | $2,468 |
| Ubrelvy | 29 | $35,455 | $1,223 |
| Fycompa | 27 | $22,683 | $840 |
| Aptiom | 17 | $20,421 | $1,201 |
See all 45 drugs
| Nurtec Odt | 53 | $73,468 | $1,386 |
| Nourianz | 19 | $46,892 | $2,468 |
| Ubrelvy | 29 | $35,455 | $1,223 |
| Fycompa | 27 | $22,683 | $840 |
| Aptiom | 17 | $20,421 | $1,201 |
| Neupro | 22 | $19,477 | $885 |
| Vimpat | 11 | $13,858 | $1,260 |
| Ajovy | 17 | $11,791 | $694 |
| Lacosamide | 42 | $8,918 | $212 |
| Memantine | 99 | $2,618 | $26 |
| Carbamazepine Er | 28 | $2,600 | $93 |
| Quetiapine | 60 | $2,109 | $35 |
| Levetiracetam | 84 | $2,064 | $25 |
| Donepezil | 259 | $2,064 | $8 |
| Rivastigmine | 11 | $2,005 | $182 |
| Levetiracetam Er | 36 | $1,815 | $50 |
| Gabapentin | 175 | $1,673 | $10 |
| Divalproex Sodium Er | 22 | $1,351 | $61 |
| Pregabalin | 71 | $1,321 | $19 |
| Carbidopa-Levodopa | 83 | $1,172 | $14 |
| Celecoxib | 47 | $1,142 | $24 |
| Divalproex | 21 | $921 | $44 |
| Carbidopa-Levodopa Er | 24 | $920 | $38 |
| Ropinirole | 44 | $627 | $14 |
| Duloxetine | 44 | $622 | $14 |
| Citalopram Hbr | 60 | $596 | $10 |
| Zonisamide | 19 | $552 | $29 |
| Lamotrigine | 40 | $522 | $13 |
| Propranolol | 30 | $412 | $14 |
| Topiramate | 43 | $311 | $7 |
| Clopidogrel | 38 | $308 | $8 |
| Trazodone | 65 | $307 | $5 |
| Phenytoin Sodium Extended | 17 | $293 | $17 |
| Cyclobenzaprine | 15 | $279 | $19 |
| Escitalopram | 34 | $244 | $7 |
| Sumatriptan | 37 | $241 | $7 |
| Clonazepam | 38 | $209 | $6 |
| Atorvastatin | 48 | $194 | $4 |
| Amitriptyline | 28 | $165 | $6 |
| Nortriptyline | 30 | $156 | $5 |
| Primidone | 19 | $95 | $5 |
| Hydralazine | 15 | $90 | $6 |
| Meclizine | 15 | $89 | $6 |
| Olanzapine | 14 | $64 | $5 |
| Naproxen | 12 | $62 | $5 |
Year by year
| 2024 | 2,207 | 315 | None | None | $373,136 |
| 2023 | 2,099 | 314 | 0% (0) | 11% | $387,149 |
| 2022 | 1,619 | 246 | 0% (0) | 10% | $201,107 |
| 2021 | 1,302 | 194 | None | 11% | $129,137 |
| 2020 | 979 | 166 | None | 14% | $123,677 |
| 2019 | 725 | 143 | 0% (0) | 14% | $79,920 |
| 2018 | 397 | 77 | 0% (0) | 20% | $58,821 |
| 2017 | 179 | 47 | None | 20% | $93,122 |
| 2016 | 142 | 68 | None | None | $37,116 |
| 2015 | 403 | 105 | 0% (0) | 22% | $61,857 |
| 2014 | 1,034 | 242 | None | 24% | $152,138 |
| 2013 | 718 | 151 | None | 32% | $93,150 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 45 drugs
| Nurtec Odt | 34 | $57,089 | $1,679 |
| Briviact | 32 | $52,338 | $1,636 |
| Inbrija | 14 | $47,963 | $3,426 |
| Nourianz | 16 | $30,352 | $1,897 |
| Lacosamide | 44 | $23,697 | $539 |
| Fycompa | 17 | $20,959 | $1,233 |
| Neupro | 17 | $16,435 | $967 |
| Lamotrigine Odt | 12 | $10,217 | $851 |
| Donepezil | 206 | $5,233 | $25 |
| Gabapentin | 226 | $4,757 | $21 |
| Levetiracetam | 102 | $4,351 | $43 |
| Memantine | 61 | $3,738 | $61 |
| Carbidopa-Levodopa | 90 | $3,337 | $37 |
| Entacapone | 14 | $3,063 | $219 |
| Divalproex Sodium Er | 25 | $2,782 | $111 |
| Temazepam | 11 | $2,700 | $245 |
| Carbamazepine Er | 22 | $2,409 | $109 |
| Ropinirole | 34 | $2,034 | $60 |
| Levetiracetam Er | 22 | $1,933 | $88 |
| Pregabalin | 33 | $1,751 | $53 |
| Rivastigmine | 12 | $1,692 | $141 |
| Duloxetine | 74 | $1,368 | $18 |
| Diclofenac | 23 | $1,293 | $56 |
| Topiramate | 60 | $1,233 | $21 |
| Celecoxib | 28 | $1,180 | $42 |
| Quetiapine | 52 | $1,159 | $22 |
| Lamotrigine | 43 | $1,154 | $27 |
| Zonisamide | 14 | $958 | $68 |
| Clopidogrel | 54 | $817 | $15 |
| Carbidopa-Levodopa Er | 22 | $762 | $35 |
| Trazodone | 77 | $732 | $10 |
| Nortriptyline | 40 | $725 | $18 |
| Sumatriptan | 36 | $696 | $19 |
| Propranolol | 29 | $582 | $20 |
| Escitalopram | 33 | $577 | $17 |
| Citalopram Hbr | 39 | $423 | $11 |
| Atorvastatin | 32 | $393 | $12 |
| Olanzapine | 18 | $343 | $19 |
| Amitriptyline | 22 | $305 | $14 |
| Cyclobenzaprine | 13 | $261 | $20 |
| Clonazepam | 21 | $217 | $10 |
| Primidone | 20 | $202 | $10 |
| Hydralazine | 13 | $125 | $10 |
| Naproxen | 19 | $124 | $7 |
| Meloxicam | 12 | $90 | $8 |
2022: 41 drugs
| Neupro | None | 34 | $27,465 | $808 |
| Vimpat | None | 23 | $24,341 | $1,058 |
| Briviact | None | 11 | $14,398 | $1,309 |
| Emgality | Migraine | 13 | $11,069 | $851 |
| Lacosamide | None | 11 | $10,613 | $965 |
| Lamotrigine Odt | None | 12 | $10,527 | $877 |
| Levetiracetam | None | 105 | $3,893 | $37 |
| Levetiracetam Er | None | 47 | $3,187 | $68 |
| Gabapentin | None | 170 | $2,567 | $15 |
| Entacapone | None | 16 | $2,460 | $154 |
| Donepezil | None | 161 | $2,112 | $13 |
| Divalproex Sodium Er | None | 18 | $2,103 | $117 |
| Carbamazepine Er | None | 21 | $1,738 | $83 |
| Quetiapine | None | 49 | $1,601 | $33 |
| Rivastigmine | None | 12 | $1,445 | $120 |
| Memantine | None | 24 | $1,429 | $60 |
| Carbidopa-Levodopa | None | 80 | $1,373 | $17 |
| Temazepam | None | 11 | $1,237 | $112 |
| Duloxetine | None | 43 | $1,216 | $28 |
| Pregabalin | None | 38 | $1,142 | $30 |
| Carbidopa-Levodopa Er | None | 22 | $981 | $45 |
| Olanzapine | None | 15 | $942 | $63 |
| Ropinirole | None | 37 | $738 | $20 |
| Tizanidine | None | 11 | $600 | $55 |
| Nortriptyline | None | 33 | $473 | $14 |
| Clopidogrel | None | 28 | $378 | $14 |
| Phenytoin Sodium Extended | None | 16 | $370 | $23 |
| Zonisamide | None | 11 | $353 | $32 |
| Citalopram Hbr | None | 36 | $340 | $9 |
| Topiramate | None | 34 | $309 | $9 |
| Propranolol | None | 14 | $240 | $17 |
| Donepezil Hcl Odt | None | 11 | $223 | $20 |
| Naproxen | None | 44 | $174 | $4 |
| Escitalopram | None | 27 | $171 | $6 |
| Lamotrigine | None | 15 | $167 | $11 |
| Trazodone | None | 28 | $145 | $5 |
| Sumatriptan | None | 14 | $138 | $10 |
| Atorvastatin | None | 12 | $72 | $6 |
| Meloxicam | None | 24 | $70 | $3 |
| Primidone | None | 17 | $60 | $4 |
| Clonazepam | None | 16 | $60 | $4 |
2021: 29 drugs
| Vimpat | None | 33 | $33,158 | $1,005 |
| Emgality | Migraine | 36 | $24,655 | $685 |
| Neupro | None | 19 | $13,338 | $702 |
| Nurtec Odt | None | 12 | $11,433 | $953 |
| Eliquis | None | 20 | $10,655 | $533 |
| Gabapentin | None | 182 | $3,052 | $17 |
| Levetiracetam | None | 118 | $2,646 | $22 |
| Levetiracetam Er | None | 39 | $1,862 | $48 |
| Pregabalin | None | 38 | $1,300 | $34 |
| Donepezil | None | 116 | $1,088 | $9 |
| Rivastigmine | None | 12 | $757 | $63 |
| Ropinirole | None | 63 | $609 | $10 |
| Duloxetine | None | 34 | $582 | $17 |
| Carbidopa-Levodopa Er | None | 17 | $572 | $34 |
| Carbidopa-Levodopa | None | 33 | $467 | $14 |
| Topiramate | None | 44 | $465 | $11 |
| Olanzapine | None | 29 | $403 | $14 |
| Donepezil Hcl Odt | None | 16 | $298 | $19 |
| Citalopram Hbr | None | 43 | $277 | $6 |
| Clopidogrel | None | 19 | $239 | $13 |
| Amitriptyline | None | 17 | $197 | $12 |
| Quetiapine | None | 13 | $180 | $14 |
| Clonazepam | None | 26 | $178 | $7 |
| Meclizine | None | 11 | $151 | $14 |
| Alprazolam | None | 12 | $124 | $10 |
| Trazodone | None | 29 | $124 | $4 |
| Escitalopram | None | 14 | $108 | $8 |
| Naproxen | None | 25 | $68 | $3 |
| Meloxicam | None | 17 | $57 | $3 |
2020: 23 drugs
| Vimpat | None | 39 | $35,781 | $917 |
| Emgality | Migraine | 34 | $27,754 | $816 |
| Neupro | None | 23 | $17,154 | $746 |
| Eliquis | None | 15 | $7,233 | $482 |
| Levetiracetam | None | 79 | $2,067 | $26 |
| Gabapentin | None | 122 | $1,548 | $13 |
| Donepezil | None | 76 | $1,357 | $18 |
| Duloxetine | None | 73 | $1,023 | $14 |
| Levetiracetam Er | None | 20 | $1,015 | $51 |
| Olanzapine | None | 54 | $1,011 | $19 |
| Carbidopa-Levodopa | None | 13 | $538 | $41 |
| Diclofenac | None | 13 | $408 | $31 |
| Topiramate | None | 28 | $386 | $14 |
| Aripiprazole | None | 12 | $369 | $31 |
| Ropinirole | None | 26 | $242 | $9 |
| Clopidogrel | None | 18 | $222 | $12 |
| Atorvastatin | None | 11 | $211 | $19 |
| Clonazepam | None | 21 | $188 | $9 |
| Naproxen | None | 26 | $173 | $7 |
| Trazodone | None | 24 | $167 | $7 |
| Citalopram Hbr | None | 26 | $129 | $5 |
| Amitriptyline | None | 15 | $115 | $8 |
| Escitalopram | None | 13 | $81 | $6 |
2019: 19 drugs
| Vimpat | None | 31 | $25,516 | $823 |
| Neupro | None | 23 | $15,411 | $670 |
| Emgality | Migraine | 14 | $8,286 | $592 |
| Eliquis | None | 11 | $4,847 | $441 |
| Gabapentin | None | 152 | $2,038 | $13 |
| Donepezil | None | 73 | $1,200 | $16 |
| Levetiracetam | None | 40 | $1,096 | $27 |
| Duloxetine | None | 42 | $877 | $21 |
| Memantine | None | 11 | $675 | $61 |
| Carbidopa-Levodopa | None | 23 | $540 | $23 |
| Clopidogrel | None | 18 | $249 | $14 |
| Topiramate | None | 21 | $164 | $8 |
| Clonazepam | None | 19 | $151 | $8 |
| Paroxetine | None | 14 | $137 | $10 |
| Escitalopram | None | 17 | $121 | $7 |
| Naproxen | None | 13 | $109 | $8 |
| Nortriptyline | None | 17 | $107 | $6 |
| Ropinirole | None | 12 | $99 | $8 |
| Trazodone | None | 20 | $66 | $3 |
2018: 14 drugs
| Vimpat | 34 | $15,516 | $456 |
| Neupro | 14 | $9,320 | $666 |
| Pyridostigmine Bromide Er | 11 | $6,014 | $547 |
| Eliquis | 11 | $5,949 | $541 |
| Levetiracetam | 41 | $762 | $19 |
| Gabapentin | 58 | $658 | $11 |
| Paroxetine | 21 | $252 | $12 |
| Duloxetine | 13 | $202 | $16 |
| Clopidogrel | 14 | $145 | $10 |
| Ropinirole | 12 | $93 | $8 |
| Topiramate | 18 | $73 | $4 |
| Donepezil | 11 | $72 | $7 |
| Nortriptyline | 13 | $56 | $4 |
| Clonazepam | 12 | $34 | $3 |
2017: 5 drugs
| Xarelto | 14 | $5,104 | $365 |
| Carbamazepine | 11 | $1,605 | $146 |
| Duloxetine | 17 | $836 | $49 |
| Ropinirole | 16 | $296 | $18 |
| Levetiracetam | 20 | $155 | $8 |
2016: 2 drugs
| Gabapentin | 14 | $528 | $38 |
| Clonazepam | 15 | $146 | $10 |
2015: 11 drugs
| Neupro | 20 | $12,668 | $633 |
| Namenda Xr | 25 | $9,552 | $382 |
| Duloxetine | 17 | $2,669 | $157 |
| Donepezil | 30 | $2,256 | $75 |
| Gabapentin | 49 | $1,526 | $31 |
| Ropinirole | 19 | $739 | $39 |
| Topiramate | 30 | $455 | $15 |
| Levetiracetam | 18 | $438 | $24 |
| Azathioprine | 12 | $168 | $14 |
| Propranolol | 14 | $94 | $7 |
| Nortriptyline | 13 | $90 | $7 |
2014: 26 drugs
| Neupro | 54 | $31,545 | $584 |
| Namenda Xr | 44 | $14,867 | $338 |
| Duloxetine | 66 | $14,723 | $223 |
| Lyrica | 40 | $10,397 | $260 |
| Vimpat | 15 | $10,062 | $671 |
| Azilect | 12 | $5,846 | $487 |
| Donepezil | 60 | $4,623 | $77 |
| Gabapentin | 129 | $4,156 | $32 |
| Mestinon | 13 | $3,709 | $285 |
| Venlafaxine Hcl Er | 12 | $2,487 | $207 |
| Divalproex Sodium Er | 14 | $1,633 | $117 |
| Levetiracetam | 48 | $1,078 | $22 |
| Topiramate | 48 | $1,075 | $22 |
| Divalproex | 19 | $694 | $37 |
| Ropinirole | 24 | $691 | $29 |
| Levetiracetam Er | 12 | $524 | $44 |
| Quetiapine | 21 | $395 | $19 |
| Primidone | 15 | $368 | $25 |
| Clopidogrel | 31 | $319 | $10 |
| Amitriptyline | 19 | $236 | $12 |
| Prednisone | 27 | $157 | $6 |
| Naproxen | 17 | $132 | $8 |
| Nortriptyline | 21 | $119 | $6 |
| Fluoxetine | 11 | $98 | $9 |
| Propranolol | 14 | $85 | $6 |
| Alprazolam | 11 | $79 | $7 |
2013: 18 drugs
| Cymbalta | 73 | $18,264 | $250 |
| Lyrica | 49 | $10,354 | $211 |
| Neupro | 22 | $9,490 | $431 |
| Aggrenox | 11 | $2,988 | $272 |
| Venlafaxine Hcl Er | 11 | $2,268 | $206 |
| Gabapentin | 59 | $1,772 | $30 |
| Levetiracetam | 49 | $1,459 | $30 |
| Donepezil | 34 | $1,154 | $34 |
| Topiramate | 35 | $1,084 | $31 |
| Ropinirole | 15 | $783 | $52 |
| Voltaren | 16 | $769 | $48 |
| Quetiapine | 19 | $714 | $38 |
| Carbidopa-Levodopa | 25 | $558 | $22 |
| Clopidogrel | 24 | $354 | $15 |
| Prednisone | 21 | $177 | $8 |
| Naproxen | 23 | $169 | $7 |
| Paroxetine | 16 | $147 | $9 |
| Nortriptyline | 15 | $58 | $4 |
Money from drug and device companies
$3,105 in 2025
| 2025 | 29 | 115 | None | $3,105 |
| 2024 | 24 | 119 | None | $3,183 |
| 2023 | 25 | 181 | None | $3,920 |
| 2022 | 23 | 142 | None | $2,975 |
| 2021 | 23 | 163 | None | $2,686 |
| 2020 | 13 | 39 | None | $912 |
| 2019 | 11 | 35 | None | $703 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Neurocrine BioSciences | Ingrezza | $691 | 22 payments
|
| Ucb | Briviact | $451 | 14 payments
|
| Pfizer | Nurtec Odt | $271 | 11 payments
|
| Aucta Pharmaceuticals | Motpoly Xr | $260 | 11 payments
|
| Abbvie | Qulipta | $247 | 11 payments
|
| CSL Behring | Hizentra | $182 | 7 payments
|
See all 115 published payments
| CSL Behring | Meals · 2025-12-22 | Hizentra | $24 |
| Aucta Pharmaceuticals | Meals · 2025-12-20 | Motpoly Xr | $24 |
| Neurelis | Meals · 2025-12-17 | Valtoco | $46 |
| Neurocrine BioSciences | Meals · 2025-12-17 | Ingrezza | $39 |
| Ucb | Meals · 2025-12-13 | Nayzilam | $46 |
| CSL Behring | Meals · 2025-12-12 | Hizentra | $28 |
| Abbvie | Meals · 2025-12-09 | Vyalev | $25 |
| Globus Medical | Meals · 2025-12-09 | Senza | $23 |
| Ucb | Meals · 2025-12-04 | Fintepla | $2 |
| Ucb | Meals · 2025-12-04 | Fintepla | $25 |
| Janssen Biotech | Meals · 2025-12-03 | None | $34 |
| Ge Healthcare | Meals · 2025-12-02 | None | $15 |
| Neurocrine BioSciences | Meals · 2025-11-26 | Ingrezza | $19 |
| Aucta Pharmaceuticals | Meals · 2025-11-26 | Motpoly Xr | $25 |
| Merz Pharmaceuticals | Meals · 2025-11-25 | Inbrija | $29 |
| Neurocrine BioSciences | Meals · 2025-11-19 | Ingrezza | $37 |
| Neurocrine BioSciences | Meals · 2025-11-19 | Ingrezza | $2 |
| Abbvie | Meals · 2025-11-11 | Vyalev | $9 |
| Aucta Pharmaceuticals | Meals · 2025-11-05 | Motpoly Xr | $25 |
| Abbvie | Meals · 2025-11-01 | Vyalev | $25 |
| Ucb | Meals · 2025-10-30 | Fintepla | $1 |
| Ucb | Meals · 2025-10-30 | Fintepla | $24 |
| Neurocrine BioSciences | Meals · 2025-10-24 | Ingrezza | $38 |
| Neurocrine BioSciences | Meals · 2025-10-23 | Ingrezza | $0 |
| CSL Behring | Meals · 2025-10-20 | Hizentra | $22 |
| Exact Sciences | Meals · 2025-10-13 | The Cologuard Plus Collection Kit | $29 |
| Ucb | Meals · 2025-10-11 | Nayzilam | $43 |
| Abbvie | Meals · 2025-10-02 | Ubrelvy | $31 |
| Pfizer | Meals · 2025-10-02 | Nurtec Odt | $24 |
| Neurocrine BioSciences | Meals · 2025-10-01 | Ingrezza | $20 |
| Aucta Pharmaceuticals | Meals · 2025-09-30 | Motpoly Xr | $23 |
| Neurocrine BioSciences | Meals · 2025-09-26 | Ingrezza | $36 |
| Neurocrine BioSciences | Meals · 2025-09-26 | Ingrezza | $24 |
| Ge Healthcare | Meals · 2025-09-26 | None | $17 |
| Jazz Pharmaceuticals | Meals · 2025-09-24 | Epidiolex | $23 |
| CSL Behring | Meals · 2025-09-22 | Hizentra | $21 |
| Neurelis | Meals · 2025-09-10 | Valtoco | $27 |
| Janssen Pharmaceuticals | Meals · 2025-09-09 | Invega Sustenna | $19 |
| Ucb | Meals · 2025-09-05 | Fintepla | $25 |
| Genentech USA | Meals · 2025-09-02 | Ocrevus Zunovo | $18 |
| Neurelis | Meals · 2025-08-27 | Valtoco | $28 |
| Jazz Pharmaceuticals | Meals · 2025-08-26 | Epidiolex | $19 |
| Merz Pharmaceuticals | Meals · 2025-08-25 | Inbrija | $37 |
| Neurocrine BioSciences | Meals · 2025-08-20 | Ingrezza | $36 |
| CSL Behring | Meals · 2025-08-18 | Hizentra | $40 |
| Neurocrine BioSciences | Meals · 2025-08-14 | Ingrezza | $22 |
| Neurocrine BioSciences | Meals · 2025-08-14 | Ingrezza | $7 |
| Ucb | Meals · 2025-08-09 | Nayzilam | $59 |
| Abbvie | Meals · 2025-08-07 | Qulipta | $32 |
| Abbvie | Meals · 2025-08-05 | Ubrelvy | $26 |
| Axsome Therapeutics | Meals · 2025-08-04 | Symbravo | $25 |
| Braeburn | Meals · 2025-07-31 | Brixadi | $32 |
| Jazz Pharmaceuticals | Meals · 2025-07-30 | Epidiolex | $24 |
| Aucta Pharmaceuticals | Meals · 2025-07-24 | Motpoly Xr | $24 |
| Collegium Pharmaceutical | Meals · 2025-07-22 | Jornay Pm | $24 |
| Ucb | Meals · 2025-07-22 | Fintepla | $21 |
| Pfizer | Meals · 2025-07-16 | Nurtec Odt | $21 |
| Aucta Pharmaceuticals | Meals · 2025-07-02 | Motpoly Xr | $23 |
| Pfizer | Meals · 2025-06-18 | Nurtec Odt | $30 |
| Otsuka America Pharmaceutical | Meals · 2025-06-10 | Rexulti | $14 |
| Neurocrine BioSciences | Meals · 2025-06-10 | Ingrezza | $130 |
| Otsuka America Pharmaceutical | Meals · 2025-06-08 | Rexulti | $29 |
| Alkermes | Meals · 2025-06-07 | Aristada | $23 |
| Insulet | Meals · 2025-06-04 | Omnipod | $25 |
| Neurelis | Meals · 2025-06-04 | Valtoco | $32 |
| Pfizer | Meals · 2025-06-04 | Nurtec Odt | $27 |
| Indivior | Meals · 2025-06-04 | Sublocade | $22 |
| Neurocrine BioSciences | Meals · 2025-05-30 | Ingrezza | $40 |
| Celgene | Meals · 2025-05-29 | Zeposia | $18 |
| Neurocrine BioSciences | Meals · 2025-05-29 | Ingrezza | $31 |
| Ucb | Meals · 2025-05-28 | Briviact | $38 |
| CSL Behring | Education · 2025-05-22 | Hizentra | $12 |
| Otsuka America Pharmaceutical | Meals · 2025-05-21 | Rexulti | $21 |
| Pfizer | Meals · 2025-05-21 | Nurtec Odt | $28 |
| Pfizer | Meals · 2025-05-21 | Nurtec Odt | $1 |
| Teva Pharmaceuticals USA | Meals · 2025-05-15 | Austedo Xr | $24 |
| Celgene | Meals · 2025-05-13 | Zeposia | $28 |
| CSL Behring | Meals · 2025-05-10 | Hizentra | $35 |
| Neurocrine BioSciences | Meals · 2025-05-05 | Ingrezza | $3 |
| Merz Pharmaceuticals | Meals · 2025-05-02 | Inbrija | $42 |
| Aucta Pharmaceuticals | Meals · 2025-04-30 | Motpoly Xr | $24 |
| Bausch Health US | Meals · 2025-04-22 | Aplenzin | $20 |
| Neurocrine BioSciences | Meals · 2025-04-22 | Ingrezza | $28 |
| Abbvie | Meals · 2025-04-18 | Ubrelvy | $15 |
| Neurocrine BioSciences | Meals · 2025-04-18 | Ingrezza | $37 |
| Pfizer | Meals · 2025-04-16 | Nurtec Odt | $30 |
| Neurocrine BioSciences | Meals · 2025-04-09 | Ingrezza | $25 |
| Abbvie | Meals · 2025-04-02 | Qulipta | $28 |
| Ucb | Meals · 2025-03-28 | Rystiggo | $46 |
| Teva Pharmaceuticals USA | Meals · 2025-03-25 | Austedo Xr | $27 |
| Abbvie | Meals · 2025-03-24 | Ubrelvy | $17 |
| Aucta Pharmaceuticals | Meals · 2025-03-21 | Motpoly Xr | $23 |
| Pfizer | Meals · 2025-03-19 | Nurtec Odt | $26 |
| Abbvie | Meals · 2025-03-18 | Qulipta | $11 |
| Neurocrine BioSciences | Meals · 2025-03-12 | Ingrezza | $39 |
| Pfizer | Meals · 2025-03-08 | Nurtec Odt | $27 |
| Tanabe Pharma America | Meals · 2025-03-04 | Radicava | $28 |
| Neurocrine BioSciences | Meals · 2025-03-01 | Ingrezza | $39 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-02-20 | Trintellix | $31 |
| Pfizer | Meals · 2025-02-19 | Nurtec Odt | $29 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-02-14 | Trintellix | $17 |
| Aucta Pharmaceuticals | Meals · 2025-02-12 | Motpoly Xr | $25 |
| Ucb | Meals · 2025-02-11 | Briviact | $38 |
| Abbvie | Meals · 2025-02-07 | Qulipta | $29 |
| Pfizer | Meals · 2025-02-04 | Nurtec Odt | $27 |
| Neurocrine BioSciences | Meals · 2025-01-31 | Ingrezza | $38 |
| Eisai | Meals · 2025-01-31 | Leqembi | $27 |
| Teva Pharmaceuticals USA | Meals · 2025-01-29 | Austedo Xr | $27 |
| Aucta Pharmaceuticals | Meals · 2025-01-29 | Motpoly Xr | $18 |
| Otsuka America Pharmaceutical | Meals · 2025-01-28 | Rexulti | $27 |
| Aucta Pharmaceuticals | Meals · 2025-01-21 | Motpoly Xr | $27 |
| Ucb | Meals · 2025-01-18 | Briviact | $42 |
| Lilly USA | Meals · 2025-01-15 | Emgality | $30 |
| Ge Healthcare | Meals · 2025-01-14 | None | $21 |
| Ucb | Meals · 2025-01-07 | Briviact | $40 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,183
| Lilly USA | Amyvid | $487 | 16 payments
|
| Ucb | Briviact | $327 | 9 payments
|
| Pfizer | Nurtec Odt | $310 | 13 payments
|
| Neurelis | Valtoco | $307 | 10 payments
|
| Abbvie | Qulipta | $262 | 13 payments
|
| Catalyst Pharmaceuticals | Fycompa | $186 | 12 payments
|
| Eisai | Leqembi | $160 | 6 payments
|
| Acorda Therapeutics | Inbrija | $153 | 9 payments
|
| Neurocrine Biosciences | Ingrezza | $130 | 1 payment
|
| SK Life Science | Xcopri | $125 | 1 payment
|
| Sumitomo Pharma America | Aptiom | $86 | 4 payments
|
| Otsuka America Pharmaceutical | Nuedexta | $81 | 3 payments
|
| Biogen | Tysabri | $77 | 3 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $70 | 3 payments
|
| Mitsubishi Tanabe Pharma America | Radicava | $63 | 2 payments
|
| Octapharma USA | Panzyga | $60 | 2 payments
|
| Kyowa Kirin | Nourianz | $56 | 2 payments
|
| Aucta Pharmaceuticals | Motpoly Xr | $53 | 3 payments
|
| Ge Healthcare | None | $41 | 2 payments
|
| Merz Pharmaceuticals | None | $36 | 1 payment
|
| Indivior | Sublocade | $35 | 1 payment
|
| Axsome Therapeutics | Auvelity | $29 | 1 payment
|
| Corium | Azstarys | $28 | 1 payment
|
| Janssen Pharmaceuticals | Spravato | $23 | 1 payment
|
2023: $3,920
| Sumitomo Pharma America | Aptiom | $602 | 36 payments
|
| Acorda Therapeutics | Inbrija | $446 | 20 payments
|
| Lilly USA | Amyvid | $375 | 18 payments
|
| SK Life Science | Xcopri | $313 | 9 payments
|
| Biogen | Tysabri | $262 | 12 payments
|
| Abbvie | Ubrelvy | $261 | 12 payments
|
| Ucb | Briviact | $240 | 7 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $237 | 15 payments
|
| Pfizer | Nurtec Odt | $185 | 10 payments
|
| Neurelis | Valtoco | $166 | 7 payments
|
| Axsome Therapeutics | Auvelity | $117 | 4 payments
|
| Impel Pharmaceuticals | Trudhesa | $104 | 6 payments
|
| GE HealthCare | None | $99 | 3 payments
|
| Otsuka America Pharmaceutical | Nuedexta | $98 | 4 payments
|
| Octapharma USA | Panzyga | $82 | 2 payments
|
| Currax Pharmaceuticals | Onzetra Xsail | $67 | 4 payments
|
| Amneal Pharmaceuticals | Rytary | $49 | 2 payments
|
| Kyowa Kirin | Nourianz | $45 | 2 payments
|
| Mitsubishi Tanabe Pharma America | Radicava | $36 | 2 payments
|
| Ipsen Biopharmaceuticals | Dysport | $32 | 1 payment
|
| Averitas Pharma | Qutenza | $31 | 1 payment
|
| Grifols USA | Gamunex-C | $21 | 1 payment
|
| Alnylam Pharmaceuticals | Onpattro | $19 | 1 payment
|
| Janssen Pharmaceuticals | Ponvory | $17 | 1 payment
|
| Idorsia Pharmaceuticals US | Quviviq | $17 | 1 payment
|
2022: $2,975
| Sunovion Pharmaceuticals | Aptiom | $434 | 21 payments
|
| Janssen Pharmaceuticals | Ponvory | $302 | 21 payments
|
| Abbvie | Ubrelvy | $270 | 15 payments
|
| SK Life Science | None | $242 | 10 payments
|
| Lilly USA | Amyvid | $241 | 9 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $210 | 15 payments
|
| Teva Pharmaceuticals USA | Austedo | $206 | 10 payments
|
| Biogen | Aduhelm | $193 | 8 payments
|
| Ucb | Briviact | $159 | 5 payments
|
| Acorda Therapeutics | Inbrija | $154 | 9 payments
|
| Otsuka America Pharmaceutical | Abilify Maintena | $124 | 1 payment
|
| Kyowa Kirin | Nourianz | $74 | 3 payments
|
| Alnylam Pharmaceuticals | Onpattro | $55 | 2 payments
|
| GRT US Holding | Qutenza | $51 | 2 payments
|
| Lundbeck | Vyepti | $47 | 2 payments
|
| Neurelis | Valtoco | $43 | 1 payment
|
| Eisai | Fycompa | $35 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $30 | 1 payment
|
| Avanir Pharmaceuticals | Nuedexta | $25 | 1 payment
|
| Banner Life Sciences | Bafiertam | $24 | 1 payment
|
| Merz Pharmaceuticals | Xeomin | $23 | 1 payment
|
| Novartis Pharmaceuticals | Kesimpta | $18 | 1 payment
|
| Abbott Laboratories | Confirm Rx | $14 | 1 payment
|
2021: $2,686
| AbbVie | Vraylar | $480 | 25 payments
|
| Biogen | Aduhelm | $256 | 13 payments
|
| Eisai | Fycompa | $245 | 37 payments
|
| Teva Pharmaceuticals USA | Ajovy | $237 | 10 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $194 | 20 payments
|
| Allergan | Botox | $190 | 11 payments
|
| Sunovion Pharmaceuticals | Aptiom | $176 | 12 payments
|
| Ucb | Briviact | $167 | 6 payments
|
| Iti | Caplyta | $124 | 1 payment
|
| SK Life Science | None | $115 | 5 payments
|
| Kyowa Kirin | Nourianz | $112 | 5 payments
|
| Lilly USA | Reyvow | $105 | 5 payments
|
| Amgen | Aimovig | $53 | 2 payments
|
| Lundbeck | Vyepti | $46 | 2 payments
|
| Merz Pharmaceuticals | Xeomin | $28 | 1 payment
|
| Ge Healthcare | None | $26 | 1 payment
|
| Medtronic | Linq II | $25 | 1 payment
|
| Alfasigma USA | None | $23 | 1 payment
|
| Alexion Pharmaceuticals | Soliris | $21 | 1 payment
|
| Janssen Pharmaceuticals | None | $17 | 1 payment
|
| Novartis Pharmaceuticals | Kesimpta | $16 | 1 payment
|
| Adamas Pharmaceuticals | Gocovri | $16 | 1 payment
|
| Avanir Pharmaceuticals | None | $13 | 1 payment
|
2020: $912
| Teva Pharmaceuticals USA | Austedo | $236 | 7 payments
|
| Allergan | Ubrelvy | $203 | 13 payments
|
| Abbott Laboratories | Infinity Dbs Pulse Generators | $140 | 2 payments
|
| Biogen | Avonex | $62 | 3 payments
|
| Lilly USA | Emgality | $52 | 3 payments
|
| Kyowa Kirin | Nourianz | $41 | 2 payments
|
| Eisai | Fycompa | $40 | 2 payments
|
| Ucb | Briviact | $39 | 2 payments
|
| Novartis Pharmaceuticals | Kesimpta | $30 | 1 payment
|
| Janssen Pharmaceuticals | None | $22 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $19 | 1 payment
|
| Portola Pharmaceuticals | Andexxa | $16 | 1 payment
|
| AbbVie | Duopa | $12 | 1 payment
|
2019: $703
| Alexion Pharmaceuticals | Soliris | $131 | 9 payments
|
| Allergan | Vraylar | $119 | 1 payment
|
| Biogen | Tysabri | $112 | 7 payments
|
| Lilly USA | Emgality | $103 | 6 payments
|
| Ucb | Briviact | $93 | 5 payments
|
| Dynasplint Systems | Dynasplint | $57 | 2 payments
|
| Teva Pharmaceuticals USA | Ajovy | $20 | 1 payment
|
| Abbott Laboratories | Infinity Dbs Pulse Generators | $20 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $20 | 1 payment
|
| AbbVie | Duopa | $15 | 1 payment
|
| Mitsubishi Tanabe Pharma America | None | $13 | 1 payment
|
Checkups this office reported
8 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Advance care plan on fileOlder patients with an advance care plan or a documented conversation about one | 100%That's most of the people this applied to. | 527 |
| Daily function assessedPatients whose ability to manage daily activities was assessed | 100%That's most of the people this applied to. | 122 |
| Dementia Associated Behavioral and Psychiatric Symptoms Screening and ManagementAs Medicare defines this measure | 100% | 122 |
| Dementia: Education and Support of Caregivers for Patients with DementiaAs Medicare defines this measure | 100% | 122 |
| Dementia: Safety Concern Screening and Follow-Up for Patients with DementiaAs Medicare defines this measure | 100% | 122 |
| Medications listed in the chartVisits where the current medication list was documented | 100%That's most of the people this applied to. | 3,790 |
| Overuse of Imaging for the Evaluation of Primary HeadacheAs Medicare defines this measure | 0% | 560 |
| Rehabilitative Therapy Referral for Patients with Parkinson's DiseaseAs Medicare defines this measure | 100% | 38 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record
Professional record
- NPI
- 1376751321
- Licence
- AZ 43362, CA A133381, CA A13381, IN 01068365A, VA 0101247258California A133381: Current · expires 2028-02-29
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X); Federal specialty code 208VP0014X (208VP0014X)
- Mailing address
- 4847 Hopyard Rd, Ste 4- 387, Pleasanton, CA, 94588
- NPI first listed
- 2007-05-21
- NPI last updated
- 2024-10-07
- NPI record certified
- 2024-10-07
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3155 Kearney St Ste 100, Fremont, CA, 94538 · 27171 Calaroga Ave Ste 1, Hayward, CA, 94545 · 555 University Ave Ste 230, Sacramento, CA, 95825 · 1081 Market Pl Ste 500, San Ramon, CA, 94583